|
Briefing
|
- Pharmaceutical Companies Meeting – President Trump convened with leading pharmaceutical companies in January 2017, asking them to move production back to the U.S. and reduce drug prices
- Hasten Drug Approval – Stated that he was committed to make local drug approval processes easier
- Intensify Competition – Encouraged more competition, even from smaller companies, to help bring down drug prices
- Address Freeloading – Announced planned new trade policy he believes will prevent foreign countries from setting limits on drug prices, which decreases revenues of pharmaceutical companies
|
|
Market Disruption
|
|
|
Sector
|
Healthcare/Health Sciences
|
|
Source
|
|
|
Original Publication Date
|
January 31, 2017
|
